Skip to main content
. 2016 Nov 17;6:37212. doi: 10.1038/srep37212

Table 2. Demographic, clinical, and cardiorespiratory variables for clinical groups.

Group SCZ (n = 34) BD (n = 21) t (df) p Hedges’ g 95% CI
Age 30.38 (8.92) 29.9 (9.55) 0.18 (40.27) 0.85 0.05 −0.49; 0.6
BMIa 25.36 (3.1) 23.71 (3.6) 1.51 (31.68) 0.14 0.49 −0.16; 1.13
HRV 6.13 (1.13) 6.27 (1.19) −0.46 (40.92) 0.65 −0.13 −0.67; 0.42
Heart rate (bpm) 72.33 (12.98) 69.64 (13.07) 0.74 (42.26) 0.46 0.2 −0.34; 0.75
RMSSD 3.54 (0.59) 3.61 (0.61) −0.44 (41.27) 0.67 −0.12 −0.66; 0.42
Respiratory peak frequency (Hz) 0.29 (0.06) 0.29 (0.05) −0.07 (48.42) 0.95 −0.02 −0.56; 0.52
PANSS totaIb 52.74 (13.6) 41.25 (7.67) 3.36 (35.76) <0.01 0.97 0.4; 1.77
Positive symptomsb 11.48 (4.26) 8.44 (2.25) 2.89 (34.93) 0.01 0.83 0.26; 1.61
Negative symptomsb 13.35 (5.54) 9.25 (2.18) 3.21 (30.36) <0.01 0.89 0.36; 1.72
General symptomsb 27.91 (6.88) 23.56 (4.79) 2.33 (37) 0.03 0.7 0.09; 1.41

Note. Values are means with standard deviations in parenthesis. SCZ = Schizophrenia spectrum disorders; BD = Bipolar spectrum disorders; BMI = Body mass index; bpm = beats per minute; PANSS = Positive and negative syndrome scale; HF-HRV = High frequency heart rate variability (log transformed); RMSSD = Root mean square of successive differences. aSZ group n = 22, BD group n = 17. bSZ group n = 23, BD group n = 16.

HHS Vulnerability Disclosure